In light of the frequent genetic alterations in the A20 locus in SSc patients leading to altered A20 expression and/or regulatory function, our findings suggest that unchecked TGF-ß signaling and persistent fibrosis in SSc might result from impaired A20 in SSc fibroblasts. The gene discussed is TNFAIP3; the disease is systemic sclerosis.